Trial Site Detail
Drug: |
PF-052112384 + PD-0325901 OR PF-052112384 + Irinotecan |
|||
|---|---|---|---|---|
Trial: |
Study Of PI3K/mTOR Inhibitors In Combination With A MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer |
|||
| Conditions: | Solid Tumors | |||
Trial Status: |
Terminated |
|||
Site name unknown, Milan |
Principal Investigator: |
|
|---|---|
Contact: |
|
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Site name unknown, Milan Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.